Literature DB >> 18545864

Natural orifice hysterectomy.

Michael D Moen1, Michael B Noone, Denise M Elser.   

Abstract

Minimally invasive surgery (MIS) such as natural orifice surgery is perceived as a relatively recent development partly because many MIS techniques utilize new technology and devices. However, a natural orifice/MIS approach for hysterectomy (vaginal hysterectomy, VH) has existed for over a century. VH is typically thought of in the realm of the urogynecologist as a component of reconstructive pelvic surgery for pelvic organ prolapse. However, current evidence supports the use of VH in women with other benign conditions such as uterine fibroids and abnormal bleeding. Despite the evidence and availability of several MIS options for hysterectomy, the majority of hysterectomies continue to be performed via laparotomy. VH is the least invasive approach to hysterectomy, and its use should be encouraged as the preferred MIS option for women requiring uterine removal for benign conditions.

Entities:  

Mesh:

Year:  2008        PMID: 18545864     DOI: 10.1007/s00192-008-0659-y

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  13 in total

1.  Flexible transgastric peritoneoscopy: a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity.

Authors:  Anthony N Kalloo; Vikesh K Singh; Sanjay B Jagannath; Hideaki Niiyama; Susan L Hill; Cheryl A Vaughn; Carolyn A Magee; Sergey V Kantsevoy
Journal:  Gastrointest Endosc       Date:  2004-07       Impact factor: 9.427

2.  Hysterectomy rates for benign indications.

Authors:  Gavin F Jacobson; Ruth E Shaber; Mary Anne Armstrong; Yun-Yi Hung
Journal:  Obstet Gynecol       Date:  2006-06       Impact factor: 7.661

3.  Observational comparison of abdominal, vaginal and laparoscopic hysterectomy as performed at a university teaching hospital.

Authors:  Allam Abdelmonem; Heather Wilson; Resad Pasic
Journal:  J Reprod Med       Date:  2006-12       Impact factor: 0.142

4.  Prospective randomized clinical trial of laparoscopically assisted vaginal hysterectomy versus total abdominal hysterectomy.

Authors:  T Falcone; M F Paraiso; E Mascha
Journal:  Am J Obstet Gynecol       Date:  1999-04       Impact factor: 8.661

5.  Hysterectomy rates in the United States 1990-1997.

Authors:  Cynthia M Farquhar; Claudia A Steiner
Journal:  Obstet Gynecol       Date:  2002-02       Impact factor: 7.661

6.  Laparoscopically assisted vaginal hysterectomy versus total abdominal hysterectomy: a prospective, randomized, multicenter study.

Authors:  R Marana; M Busacca; E Zupi; N Garcea; P Paparella; G F Catalano
Journal:  Am J Obstet Gynecol       Date:  1999-02       Impact factor: 8.661

7.  Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial.

Authors:  Mark Sculpher; Andrea Manca; Jason Abbott; Jayne Fountain; Su Mason; Ray Garry
Journal:  BMJ       Date:  2004-01-07

8.  A randomised prospective trial comparing laparoscopic and abdominal hysterectomy.

Authors:  J H Olsson; M Ellstrom; M Hahlin
Journal:  Br J Obstet Gynaecol       Date:  1996-04

9.  Is laparoscopic hysterectomy a waste of time?

Authors:  R E Richardson; N Bournas; A L Magos
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321

10.  Randomized comparison of laparoscopy-assisted vaginal hysterectomy with standard vaginal hysterectomy in an outpatient setting.

Authors:  R L Summitt; T G Stovall; G H Lipscomb; F W Ling
Journal:  Obstet Gynecol       Date:  1992-12       Impact factor: 7.661

View more
  2 in total

1.  Hysterectomy and ovarian cystectomy using natural orifice transluminal endoscopic surgery: An initial experience at Tzu Chi General Hospital.

Authors:  Dah-Ching Ding; Tang-Yuan Chu; Mun-Kun Hong
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2017 Oct-Dec

Review 2.  Systematic Review and Meta-Analysis on Hysterectomy by Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) Compared to Laparoscopic Hysterectomy for Benign Indications.

Authors:  Susanne Housmans; Nargis Noori; Supuni Kapurubandara; Jan J A Bosteels; Laura Cattani; Ibrahim Alkatout; Jan Deprest; Jan Baekelandt
Journal:  J Clin Med       Date:  2020-12-07       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.